Cargando…
Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?
Autores principales: | Demirtas, Coskun Ozer, Yilmaz, Yusuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349491/ https://www.ncbi.nlm.nih.gov/pubmed/35949724 http://dx.doi.org/10.14744/hf.2020.2020.0024 |
Ejemplares similares
-
High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis
por: Ergenc, Ilkay, et al.
Publicado: (2021) -
Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
por: Kaya, Eda, et al.
Publicado: (2020) -
The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020) -
Ground Breaking and Breaking Ground
Publicado: (2001) -
Is There a More Practical Way for Screening Minimal Hepatic Encephalopathy?
por: Tosun, Şerife Değirmencioğlu, et al.
Publicado: (2023)